YM17E
{[allProObj[0].p_purity_real_show]}
货号：A1176487
YM17E 是一种酰基辅酶A:胆固醇酰基转移酶 (AC AT
YM17E 化学结构
YM17E 3D分子结构
规格
价格
会员价
库存
数量
{[ item.pr_size ]}
{[ getRatePrice(item.pr_rmb, 1,1) ]}
{[ getRatePrice(item.pr_rmb_sale, 1,1) ]}
{[ suihuo_tips(item.pr_am, item.pr_size) ]}
{[ getRatePrice(item.pr_rmb, 1,1) ]}
{[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]}
{[ suihuo_tips(item.pr_am, item.pr_size) ]}
{[ getRatePrice(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_am, item.pr_size) ]}
{[ getRatePrice(item.pr_rmb_sale, 1,1) ]}
{[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]}
{[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]}
现货
咨询
-
+
YM17E 纯度/质量文件 产品仅供科研
货号：A1176487
标准纯度：
{[allProObj[0].p_purity_real_show]}
产品说明书
全球学术期刊中引用的产品
• Nat. Biomed. Eng. , 2024, 8, 1412-1424. Ambeed. A538667 ,
A631746
]
• JMC , 2024. Ambeed. A356070
]
• BMC Cancer , 2024, 24(1): 1415. Ambeed. A209020
]
• J. Am. Soc. Mass Spectrom. , 2024, 35(12): 3192-3202. Ambeed. A961334 ,
A292945 ,
A230770 ,
A300620 ,
A1114580 ,
A1159765 ,
A206238
]
• PloS One , 2024, 19(11): e0308060. Ambeed. 更多 >
YM17E 质控信息
Penfluridol
+
Dopamine receptor, Ki: 1.6 μM
98%
Ansofaxine HCl
++
Dopamine receptor, IC50: 491 nM
98%
Tetrahydroberberine,THB
+
98+%
Prochlorperazine Maleate
✔
95%
Olanzapine
✔
99+%
Trifluoperazine
++++
Dopamine D2 receptor, IC50: 1.1 nM
98%
Ropinirole hydrochloride
++
99%
Lurasidone
++++
98%
Levosulpiride
✔
99+%
Pridopidine
✔
95%
Metoclopramide
✔
✔
99+%
Molindone HCl
✔
98%
Sulpiride
✔
99+%
Perospirone
++++
99%
Perospirone HCl
++++
98+%
Phenothiazine
✔
98%
Pimozide
+
Dopamine D1 receptor, Ki: 6600 nM
+++
Dopamine D2 receptor, Ki: 3.0 nM
++++
Dopamine D3 receptor, Ki: 0.83 nM
98%
Rotundine
++
D1 receptor, IC50: 166 nM
+
D2 receptor, IC50: 1.47 μM
+
D3 receptor, IC50: 3.25 μM
98%
Domperidone
✔
99+%
ONC206
✔
97%
Pimethixene maleate
++
Dopamine D1 Receptor, pKi: 6.37
+++
Dopamine D2 Receptor, pKi: 8.19
++
Dopamine D4.4 Receptor, pKi: 7.54
97%
Loxapine succinate
++
D2 receptor (Human), Ki: 62 nM
D1 receptor (human), Ki: 26 nM
++
D2 receptor (human), Ki: 24 nM
D2 receptor (bovine), Ki: 26 nM
+++
D4 receptor (human), Ki: 7.5 nM
99%
Chlorprothixene
+++
+++
+++
+++
98%
SCH-23390 HCl
++++
D1 dopamine receptor, Ki: 0.2 nM
++++
D5 dopamine receptor, Ki: 0.3 nM
98%
MPP+ iodide
✔
97%
σ1 Receptor antagonist-1
+
97%
Benztropine mesylate
++
98%
Azaperone
✔
98%
Ziprasidone HCl
✔
98+%
Paliperidone
✔
98%
Alizapride HCl
✔
99+%
Amisulpride
✔
98%
Quetiapine hemifumarate
✔
Adrenergic Receptor
98%
Clozapine N-oxide
✔
99%
展开
1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多，抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用，但抑制强度暂时没有相关数据。
YM17E 生物活性
描述
YM17E is equally effective in inhibiting ACAT activity in the liver as it is in the intestines, with IC50 values of 45 and 34 nM, respectively[2]
YM17E 动物研究
Animal study
Administered orally at doses of 3, 10, and 30 mg/kg daily, YM17E reduces total cholesterol, cholesterol esters, and non-HDL cholesterol in a dose-dependent manner. Intravenous injection of YM17E does not significantly lower total cholesterol and cholesterol ester levels in the liver, but oral administration does, and it is dose-dependent. Under the administration route of intravenous injection, YM17E significantly inhibits hepatic ACAT activity in a dose-dependent manner at doses of 3, 5, and 10 mg/kg. Following both oral and intravenous administration, YM17E significantly increases the clearance rate of 125 I-LDL in rats fed an atherosclerotic diet[1]
YM17E 参考文献
YM17E 实验方案
计算器
摩尔计算器
总药量计算器
工作液计算器
存储液制备
1mg
5mg
10mg
1 mM
5 mM
10 mM
1.53mL
0.31mL
0.15mL
7.66mL
1.53mL
0.77mL
15.32mL
3.06mL
1.53mL
YM17E 技术信息
搜索
